NanoVibronix, Inc. is a medical device company focused on developing medical devices utilizing its patented low intensity surface acoustic wave (SAW) technology. The technology allows for the creation of low-frequency ultrasound waves that can be utilized for a variety of medical applications, including for disruption of biofilms and bacterial colonization, as well as for pain relief. The Company's primary products include PainShield and UroShield, which are portable devices suitable for administration at home or in any care setting. PainShield is a patch-based therapeutic ultrasound technology to treat pain, muscle spasm and joint contractures by delivering a localized ultrasound effect to treat pain and induce soft tissue healing in a targeted area. UroShield is an ultrasound-based product that is designed to prevent bacterial colonization and biofilm in urinary catheters, increase antibiotic efficacy and decrease pain and discomfort associated with urinary catheter use.
Unternehmens-codeNAOV
Name des UnternehmensNanovibronix Inc
IPO-datumApr 24, 2015
Gegründet am2003
CEOMr. Brian M. Murphy
Anzahl der mitarbeiter15
WertpapierartOrdinary Share
GeschäftsjahresendeApr 24
Addresse969 Pruitt Ave,
StadtTYLER
BörseNASDAQ Capital Market Consolidated
LandUnited States of America
Postleitzahl77569
Telefon19142333004
Websitehttps://nanovibronix.com/
Unternehmens-codeNAOV
IPO-datumApr 24, 2015
Gegründet am2003
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.

Keine Daten